Last update 12 Oct 2026

VT-101(Jiangsu Wanbang)

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Bile Duct NeoplasmsBreast CancerColorectal Cancer+ [5]
Inactive Indication
Non-Muscle Invasive Bladder Neoplasms
Originator Organization
Jiangsu Wanbang Medical Technology Co., Ltd.Jiangsu Wanbang Medical Technology Co., Ltd.Jiangsu Wanrong Biomedical Technology Co., Ltd.
Active Organization
Jiangsu Wanrong Biomedical Technology Co., Ltd.Jiangsu Wanbang Medical Technology Co., Ltd.Jiangsu Wanbang Medical Technology Co., Ltd.Shanghai Obio Technology (Group) Corp., Ltd.Shanghai Obio Technology (Group) Corp., Ltd.
Inactive Organization
Affiliated Hospital of Xuzhou Medical UniversityAffiliated Hospital of Xuzhou Medical University
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VT-101(Jiangsu Wanbang)
NCT06632964
/ Unknown statusPhase 1IIT
An Open-label, Single-arm Exploratory Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer
100 Clinical Results associated with VT-101(Jiangsu Wanbang)
Login to view more data
100 Translational Medicine associated with VT-101(Jiangsu Wanbang)
Login to view more data
100 Patents (Medical) associated with VT-101(Jiangsu Wanbang)
Login to view more data
100 Deals associated with VT-101(Jiangsu Wanbang)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bile Duct NeoplasmsPhase 1
China
Jiangsu Wanrong Biomedical Technology Co., Ltd.
12 Oct 2026
Breast CancerPhase 1
China
Jiangsu Wanrong Biomedical Technology Co., Ltd.
12 Oct 2026
Colorectal CancerPhase 1
China
Jiangsu Wanrong Biomedical Technology Co., Ltd.
12 Oct 2026
Liver CancerPhase 1
China
Jiangsu Wanrong Biomedical Technology Co., Ltd.
12 Oct 2026
MelanomaPhase 1
China
Jiangsu Wanrong Biomedical Technology Co., Ltd.
12 Oct 2026
Pancreatic CancerPhase 1
China
Jiangsu Wanrong Biomedical Technology Co., Ltd.
12 Oct 2026
Non-Muscle Invasive Bladder NeoplasmsPhase 1
China
Affiliated Hospital of Xuzhou Medical UniversityAffiliated Hospital of Xuzhou Medical University
18 Sep 2024
Advanced breast cancerIND Approval
China
Shanghai Obio Technology (Group) Corp., Ltd.Shanghai Obio Technology (Group) Corp., Ltd.
14 Nov 2023
Advanced breast cancerIND Approval
China
Jiangsu Wanbang Medical Technology Co., Ltd.Jiangsu Wanbang Medical Technology Co., Ltd.
14 Nov 2023
Advanced Head and Neck Squamous Cell CarcinomaIND Approval
China
Shanghai Obio Technology (Group) Corp., Ltd.Shanghai Obio Technology (Group) Corp., Ltd.
14 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free